Remove Networking Remove Pharma Remove Prescription Remove Transportation
article thumbnail

Addressing the Polypharmacy Problem

PM360

If one of those conditions is type 2 diabetes, that person may be taking seven prescription medications, 1 managing two or more additional chronic conditions, 2 and paying $13,000 per year on healthcare. senior adults (aged 65+) 7 taking five or more prescription medications. 3 They are also 2.6 In the U.S., 5 This links to 22% of U.S.

article thumbnail

Nine for 2023, part three: thriving or surviving?

pharmaphorum

Pharma will be focusing more on relevant research, support, and a better mix of non-promotional and promotional interaction. Given the funding environment for innovative medicines that is faced by all pharma, large or small, once assets are approved, however, this 2023 reset seems a necessary response.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Diversity and inclusion in oncology clinical trials

Clarify Health

In this blog, we take a close look at health equity in oncology trials specifically, assessing how the lack of diversity and inclusion has impacted cancer patients and the pharma industry’s key initiatives to address it. J National Comprehensive Cancer Network. 1] Zaorsky NG, Zhang Y, Walter V, Tchelebi LT, Chinchilli VM, Gusani NJ.

article thumbnail

The Value of Precision Livestock Farming (PLF) in 2022

Celeritas

Other sensors include pedometers , accelerometers , pressure sensors , and temperature sensors which are often integrated into foot tags to detect estrus, ill health, and weight gain and connected to a network to establish an Internet of Things. Prescriptive Analytics: . Prescriptive Analytics: .

article thumbnail

Embedding the Patient Point of View in Everything You Do

PM360

Cure” put me on a path to work across a network of incredibly smart, passionate, and well-meaning stakeholders to connect dots, create forums for sharing ideas, drive patient-centered approaches, and eliminate lost-in-translation moments. Empathy needs to be a core strategic imperative for pharma brands.

article thumbnail

The Future of RWE in Clinical Trial Design and Recruitment

Clarify Health

Prior to him walking in, the sponsor and pharmacy already have a holistic view of his patient journey and understand factors affecting his lifestyle, such as whether he buys cigarettes or lacks transportation. About 10% of pharma companies at this point have active efforts but we’ve started to see some approvals.

article thumbnail

The Future of RWE in Clinical Trial Design and Recruitment

Clarify Health

Prior to him walking in, the sponsor and pharmacy already have a holistic view of his patient journey and understand factors affecting his lifestyle, such as whether he buys cigarettes or lacks transportation. About 10% of pharma companies at this point have active efforts but we’ve started to see some approvals.